GO
Loading...

Enter multiple symbols separated by commas

Food and Staples Retailing Drug Retail

More

  • May 1- CVS Health Corp reported higher-than-expected quarterly results on Friday, helped by increased revenue from its specialty pharmacy services and increased claim processing. CVS, the No. 2 U.S. drugstore operator, also raised the low end of its 2015 profit forecast to $5.08 a share from $5.05 before special items, while keeping the high end at 5.19.

  • April 9- Drugstore operator Walgreens Boots Alliance Inc on Thursday reported a higher-than-expected quarterly profit and said it would widen its cost-cutting program, sending its shares higher. Walgreens said on Thursday that it had identified ways to increase the program to a projected $1.5 billion by the August year-end of fiscal 2017..

  • April 8- Rite Aid Corp reported a better-than-expected quarterly profit on Wednesday, and expected a renewed distribution agreement with McKesson Corp along with the remodeling of its wellness stores to benefit fiscal 2016 earnings. Rite Aid is the No. 3 drugstore chain by sales in the U.S. behind Walgreen Boots Alliance and CVS Health Corp.

  • Rite Aid quarterly same-store sales rise 4.5 pct Wednesday, 8 Apr 2015 | 7:24 AM ET

    April 8- Drugstore chain operator Rite Aid Corp's quarterly revenue rose 3.8 percent, helped by strong prescription sales that drove better-than-expected same-store sales growth. Rite Aid's shares rose 2.9 percent to $8.95 in premarket trading on Wednesday. The latest quarter included an income tax benefit of $1.72 billion, or $1.67 per share, Rite Aid said.

  • FRANKFURT, March 27- Nine months after Apple and IBM began working together on building mobile apps for businesses, some of the first fruits are about to appear at UK pharmacy chain Boots, which has begun equipping store employees with iPads to serve shoppers in the aisles. Companies across dozens of different industries are now eyeing how these mobile business...

  • One iconic singer has high hopes for a pot brand Friday, 27 Mar 2015 | 8:43 AM ET
    Willie Nelson performs at the MusiCares 2015 Person Of The Year gala honoring Bob Dylan in Los Angeles, Feb. 6, 2015.

    Music icon Willie Nelson is going into the weed business, according to a pot activist.

  • Feb 17- CVS Health Corp, the second-largest U.S. pharmacy chain operator, has warned that a new class of drugs being developed to lower "bad" cholesterol could cost the U.S. healthcare system as much as $150 billion per year. The new class of cholesterol drugs called PCSK9 inhibitors could be priced in the range of $7,000- $12,000 per year, CVS said.

  • Feb 11- Drugstore operator Rite Aid Corp agreed to buy pharmacy benefit manager EnvisionRx for about $2 billion, looking to cut drug procurement costs as reimbursement rates fall. Rite Aid's deal comes nearly a decade after larger rival CVS Health Corp bought Caremark Rx for $21 billion, the only other example of a drug chain buying a benefits manager.

  • Feb 11- Drugstore operator Rite Aid Corp said it would buy pharmacy benefit manager EnvisionRx for about $2 billion, entering the business of administering health plan benefits. The deal will help Rite Aid compete better with CVS Health Corp, which bought Caremark Rx for $21 billion in 2006.. The acquisition of EnvisionRx will also give Rite Aid access to more...

  • Feb 11- Drugstore operator Rite Aid Corp said it would buy pharmacy benefit manager EnvisionRx for about $2 billion, to enter the business of administering drug benefits for employers. The third-largest U.S. drug-store chain said it would pay about $1.8 billion in cash and $200 million in stock. Rite Aid's shares rose 3 percent to $7.88 in premarket trading.

  • Feb 10- CVS Health Corp reported a better-than-expected quarterly net revenue, boosted by growth in its Medicaid business and strength in specialty drug sales. CVS became the first national drugstore chain in the United States to take cigarettes off its shelves from Oct. 1. CVS Health has focused on developing its specialty pharmacy business, which sells drugs...

  • Feb 10- CVS Health Corp, the No. 2 U.S. drugstore operator, reported a better-than-expected quarterly net revenue, helped by a jump in pharmacy same-store sales and strength in its specialty pharmacy business. CVS Health has focused on developing its specialty pharmacy business, which sells drugs to treat complex diseases such as multiple sclerosis, rheumatoid...

  • Orexigen CEO: Excited about obesity drug progress Tuesday, 13 Jan 2015 | 2:22 PM ET
    Orexigen CEO: Excited about obesity drug progress

    Mike Narachi, Orexigen CEO, speaks with CNBC's Meg Tirrell about its obesity drug and program.

  • Biogen Idec beefs up pain pipeline Monday, 12 Jan 2015 | 3:16 PM ET
    Biogen Idec beefs up pain pipeline

    Dr. George Scangos, Biogen Idec CEO, discusses new therapies in multiple sclerosis, Alzheimer's disease and pain.

  • America going to pot Friday, 2 Jan 2015 | 10:48 AM ET
    America's going to pot

    CNBC's Jane Wells shares her top three predictions for the pot industry this year, including changing bank regulations and the beginning of voters' remorse where it's legal.

  • Walgreen profit rises 16% on record prescriptions Tuesday, 23 Dec 2014 | 9:23 AM ET
    A Walgreens store is shown in Homestead, Fla.

    U.S. drugstore chain operator Walgreen reported a 16 percent rise in quarterly profit, helped by a record number of prescriptions filled.

  • Lottery ticket sector of 2015 Monday, 22 Dec 2014 | 12:46 PM ET
    Lottery ticket sector of 2015

    Mark Fisher, MBF Clearing Corp. chairman, shares his favorite stock in the biotech space.

  • Cramer's view of AbbVie-Express Scripts deal Monday, 22 Dec 2014 | 8:52 AM ET
    Cramer's view of AbbVie-Express Scripts deal

    Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.

  • Express Scripts' significant discount on hep C drug Monday, 22 Dec 2014 | 8:50 AM ET
    Hepatitis C virus

    Express Scripts Medical Chief Steve Miller, provides insight to his company's deal with AbbVie. The two companies have come to a deal which gives Express Scripts a significant discount on the hepatitis C drug.

  • Express Scripts gets deal for AbbVie's hepatitis C drug

    CNBC's Meg Tirrell provides insight to a newly approved hepatitis C drug from AbbVie, which Express Scripts made an exclusive deal for a significant discount on the drug.